Related Experiment Video
Updated: Apr 30, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Short-term outcomes of Quebec's ban on flavoured vaping products on adolescent electronic cigarette use: a 2022-2024
Slim Haddad1,2,3, Richard E Bélanger4,5, Natalia Poliakova1
1VITAM ‒ Centre de recherche en santé durable, Quebec City, QC, Canada.
Objectives:
Studies evaluating the outcomes of flavoured vaping product sales bans on adolescent vaping remain scarce, often inconclusive, and of limited generalizability, as they rely predominantly on US data. This study examines the short-term outcomes of such legislation implemented in Quebec (Canada) in October 2023.
Methods:
A pretest-posttest design with a nonequivalent control group was used, drawing on data from the 2022, 2023 (pre-intervention), and 2024 (post-intervention) waves of the COMPASS study. The exposed group included 4540 adolescents from 68 Quebec schools, and the comparison group included 1491 adolescents from 39 Ontario schools. Indicators derived from self-reported current vaping (past-30-days) were analysed: non-use, daily use, initiation, reduction, mean magnitude of reduction, and cessation.
Results:
Between 2023 and 2024, difference-in-differences analyses revealed no significant between-group differences across all six outcomes examined: non-use (-0.7 percentage point; 95% CI [-2.4, 1.1]), daily use (+ 0.6 point; [-0.2, 1.4]), initiation (+ 1.6 point; [-1.1, 4.3]), reduced use (-9.7 points; [-20.7, 1.3]), mean magnitude of use reduction (+ 0.3 points on the ordinal scale; [-0.1, 0.7]), and cessation (-3.6 points; [-14.9, 7.8]).
Conclusion:
The results do not provide evidence of short-term outcomes of the Quebec legislation and suggest the need for adjusted approaches. Such adjustments may involve strengthening both the design and implementation of interventions. Future research with longer follow-up periods is needed to identify the most effective measures to protect adolescents.
More Related Videos
Related Concept Videos
Vaporization
Vapor Pressure Lowering
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

